Table II.
Univariate analysis of significant prognostic factors for overall survival in the GC patients.
| Variable | Overall survival
|
||
|---|---|---|---|
| n | Events | P-value | |
| Age at diagnosis (years) | |||
| ≤65 | 87 | 31 | 0.311 |
| >65 | 33 | 17 | |
| Gender | |||
| Male | 77 | 31 | 0.959 |
| Female | 43 | 17 | |
| Tumor size (cm) | |||
| ≤5 | 86 | 26 | 0.03 |
| >5 | 34 | 22 | |
| WHO classification | |||
| 1 | 104 | 38 | 0.469 |
| 2 | 7 | 4 | |
| 3 | 9 | 6 | |
| TNM score | |||
| 1 | 14 | 2 | 0.006 |
| 2 | 31 | 4 | |
| 3 | 22 | 5 | |
| 4 | 32 | 19 | |
| 5 | 16 | 13 | |
| 6 | 5 | 5 | |
| Differentiation | |||
| 1 | 13 | 3 | 0.612 |
| 2 | 63 | 25 | |
| 3 | 44 | 20 | |
| SERPINB5 | |||
| Weakly positive | 56 | 11 | 0.005 |
| Positive | 64 | 37 | |
| KLK10 | |||
| Weakly positive | 88 | 19 | 0.001 |
| Positive | 32 | 29 | |
| KLK11 | |||
| Negative | 66 | 36 | 0.016 |
| Positive | 56 | 12 | |
| HPN | |||
| Negative | 84 | 42 | 0.014 |
| Positive | 36 | 6 | |